MindWalk Holdings (HYFT) Curent Deferred Tax Liability (2020 - 2024)
MindWalk Holdings' (HYFT) quarterly Curent Deferred Tax Liability came in at $205642.6 in Q1 2024, down 48.06% year-over-year from $395904.6 in Q1 2023, and little changed quarter-over-quarter from $205760.8 in Q4 2023.
Analysis
MindWalk Holdings (HYFT) Curent Deferred Tax Liability (2020 - 2024) Analysis & Trends
MindWalk Holdings (HYFT) has reported Curent Deferred Tax Liability for 4 consecutive years, with $205642.6 the latest figure, recorded in Q1 2024.
- On a quarterly basis, Curent Deferred Tax Liability fell 48.06% year-over-year to $205642.6 in Q1 2024; TTM through Jan 2024 was $205642.6, a 48.06% decrease from a year earlier, with the FY2023 full-year figure at $209257.3, down 47.2% from the prior year.
- Curent Deferred Tax Liability was $205642.6 for Q1 2024 at MindWalk Holdings, roughly flat from $205760.8 in the prior quarter.
- Over five years, Curent Deferred Tax Liability peaked at $735803.8 in Q2 2020 and troughed at $205281.8 in Q3 2023.
- A 4-year average of $343653.6 and a median of $372435.5 in 2022 frame the typical range for Curent Deferred Tax Liability.
- Across the five-year window, Curent Deferred Tax Liability sank 44.88% in 2023 and tumbled 48.06% in 2024, its largest moves.
- Over 4 years, Curent Deferred Tax Liability stood at $735803.8 in 2020, then tumbled by 49.15% to $374189.0 in 2022, then plunged by 45.01% to $205760.8 in 2023, then fell by 0.06% to $205642.6 in 2024.
- The last three Curent Deferred Tax Liability figures came in at $205642.6 (Q1 2024), $205760.8 (Q4 2023), and $205281.8 (Q3 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Curent Deferred Tax Liability (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 42.16 Bn | 40.08 Bn | 1.44 Bn | - |
| 2 | Medpace Holdings | 16.38 Bn | 15.88 Bn | 201.64 Mn | - |
| 3 | Charles River Laboratories International | 13.09 Bn | 12.90 Bn | 452.07 Mn | - |
| 4 | Icon | 12.36 Bn | 11.44 Bn | 479.29 Mn | - |
| 5 | Fortrea Holdings | 1.58 Bn | 1.41 Bn | 139.20 Mn | - |
| 6 | Evotec SE | 626.85 Mn | 200.98 Mn | - | 8.22 Mn |
| 7 | Ginkgo Bioworks Holdings | 422.24 Mn | 337.71 Mn | 18.44 Mn | - |
| 8 | Champions Oncology | 70.27 Mn | 70.27 Mn | 7.03 Mn | - |
| 9 | MindWalk Holdings | 59.60 Mn | 51.32 Mn | 1.82 Mn | - |
| 10 | VivoSim Labs | 1.45 Mn | 1.45 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jan 31, 2024 | 205,642.57 |
| Oct 31, 2023 | 205,760.79 |
| Jul 31, 2023 | 205,281.84 |
| Apr 30, 2023 | 205,455.67 |
| Jan 31, 2023 | 395,904.62 |
| Oct 31, 2022 | 374,189.03 |
| Jul 31, 2022 | 372,435.49 |
| Apr 30, 2022 | 392,408.90 |
| Apr 30, 2020 | 735,803.80 |